JANESVILLE, WI – November 26, 2013 SHINE Medical Technologies, Inc. (SHINE), a Wisconsin-based company dedicated to being the world leader in safe, clean, affordable production of medical isotopes and cancer treatment elements, announced today that it will present an update on its progress in the development and planning for its Janesville medical isotope facility on Tuesday, December 3rd at the Holiday Inn Express, 3100 Wellington Place in Janesville.The session is scheduled to run from 4:30 to 5:30 p.m. SHINE invites anyone in the Janesville community interested in learning more about SHINE or its planned facility in Janesville to attend. There will be an opportunity at the end of the presentation for questions and answers.
“Since our last meeting, the Nuclear Regulatory Commission (NRC) has begun its review of our construction application. While it is still too soon to provide any definitive timeframe, the NRC’s review and approval of the plant design and incorporated safety elements is an absolute requirement before any plant construction can begin,” said Greg Piefer, Ph.D., founder and chief executive officer of SHINE.
This information session is part of SHINE’s commitment to Janesville to keep the community informed and respond to questions on its progress toward building a manufacturing facility in Janesville that will provide molybdenum-99 (moly-99) and other medical isotopes for millions of people each year.